Related Experiment Video
Updated: Jul 21, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Global Comparison of Readmission Rates for Patients With Heart Failure
Farid Foroutan1, Daniel G Rayner2, Heather J Ross3
1Ted Rogers Centre for Heart Research, University Health Network, Toronto, Ontario, Canada.
Hospital readmission and mortality rates for heart failure (HF) patients remain high globally. International variations in HF readmission were not explained by healthcare spending or patient comorbidities.
Area of Science:
- Cardiology
- Public Health
- Health Services Research
Background:
- International comparisons of heart failure (HF) readmission rates are lacking.
- Understanding global variations in HF outcomes can inform patient management strategies.
- Previous studies have not comprehensively analyzed international HF readmission and mortality data.
Approach:
- Systematic review and meta-analysis of observational studies on hospitalized adult HF patients.
- Included studies published between January 2010 and March 2021, sourced from MEDLINE, Embase, and CENTRAL.
- Utilized a random-effects model for meta-analysis of proportions and meta-regression to explore heterogeneity.
Key Points:
- Analyzed 24 papers for 30-day and 23 for 1-year readmission, involving 1.5 million individuals.
- 30-day readmission rate was 13.2% (95% CI: 10.5%-16.1%); 1-year rate was 35.7% (95% CI: 27.1%-44.9%).
- 30-day mortality was 7.6% (95% CI: 6.1%-9.3%); 1-year mortality was 23.3% (95% CI: 20.8%-25.9%).
Conclusions:
- Hospitalized heart failure patients face high global readmission and mortality rates.
- Significant international variability in HF readmission rates exists.
- This variability could not be explained by healthcare expenditure, mortality risk, or comorbidities.
More Related Videos
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure I: Introduction
Heart Failure V: Medical Management
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure Drugs: β-Blockers

